Search Results
Viewing: 421-430 of 3138 | All
Article
June 2011
Dr. Paul Martin discusses how the CMAH gene deletion in the mdx mouse model of duchenne muscular dystrophy helps better mimic the more severe aspects of DMD.
Article
August 2011
Dr. Valérie Allamand discusses the function of Selenoprotein N in muscle and its link to neuromuscular disorders.

Surgical Quality Improvement Research Fellowship
Candidates who are interested in Quality Improvement are encouraged to apply for Nationwide Children's Hospital's two-year Surgical Quality Improvement Research Fellowship.
Article
Wang Lab
Under the direction of Ruoning Wang, PhD, the Wang Lab conducts research to understand the fundamental questions related to cell metabolism, cell cycle, and cell fate determination in various physio-pathological contexts.
Article
Leukemias and Lymphomas
Leukemia and lymphomas are some of the most common types of cancer in children, affecting one in three children who are diagnosed with pediatric cancer. These diseases are cancers of white blood cells and immune system, hindering the ability of the body to fight off infections.
News
Study Finds Adolescents with Concussion May Benefit from More Activity Earlier
Researchers at Nationwide Children’s Hospital have found that when it comes to concussion recovery, activity type matters. In a study published today in British Journal of Sports Medicine, researchers found that limiting screen time and returning to school early following a concussion may speed up recovery.
News
Nationwide Foundation Announces Gift to Transform the Lives of Children Through Genomics Research at Nationwide Childrens Hospital
The Nationwide Foundation today announced a new $10 million gift for the Nationwide Pediatric Innovation Fund at Nationwide Children’s Hospital to help make significant progress toward important research in genomics.
News
Nationwide Children's Part of Multi-Million Dollar Research Center to Solve the Mystery of Premature Birth
Three major Ohio universities and four hospitals have joined with the March of Dimes Foundation to establish a new collaborative research program aimed exclusively at finding the unknown causes of premature birth. The March of Dimes intends to invest $10 million in the program over five years.
Article
Lynch Lab
Under the direction of Thomas Lynch, PhD, the Lynch Lab leverages cutting-edge animal models, cell and tissue culture techniques, and transcriptomics to study region-specific cell differentiation, renewal and regenerative plasticity in the conducting airways of the lung.
Article
Kararoudi Lab
Under the direction of Meisam Naeimi Kararoudi, DVM, PhD, the Kararoudi Lab aims to develop novel cancer immunotherapies through CRISPR-Cas9 genome editing and screening technology.